Medicare spending would increase $2.0 to $5.1 billion with lecanemab, say researchers
If eligible patients received lecanemab, Medicare would spend an extra $2.0 to $5.1 billion annually, according to a research letter published online May 11 in JAMA Internal Medicine to coincide with the annual meeting of ...
May 18, 2023
0
5